Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Carnitine PD Solution for Insulin Sensitivity in CAPD
NCT00755404Phase 2Withdrawn
- Sponsor
- Iperboreal Pharma
- Start
- Jun 2007
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levocarnitine in type 2 diabetes mellitus (T2DM), sponsored by Iperboreal Pharma. Planned start Jun 2007; status: withdrawn.
02
Drugs
levocarnitine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00755404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00755404.